like blood group O (universal donor blood type). [4] [5] [6] In fact, results of A2-incompatible kidney transplantation (A2i: blood group A2 or A2B donor → blood group B recipient) have demonstrated similar graft and patient outcomes as ABO compatible (ABOc) DDKT (blood group B or O donor → blood group B recipient) without the need for immune modulation. 7, 8 Furthermore, one organ procurement organization found an increase of over 30% in the transplantation rate for blood group B candidates, following preferential allocation of A2
and A2B donor kidneys in their region. 9 However, despite the excellent allograft and patient outcomes reported, A2i transplantation has been underutilized in the past, with less than 15% of A2 kidneys from deceased donors used for A2i
DDKT recipients as of 2010. 10 Not surprisingly, given the encouraging early results following A2i transplantation and the potential to mitigate disparities in access to DDKT among predominately minority blood group B candidates, the new kidney allocation system (KAS, implemented December 2014) incorporated a provision for the preferential allocation of A2 and A2B kidneys to blood group B transplant candidates. To date, no study has assessed the impact of KAS on A2i DDKT rates or assessed the impact of this aspect of the policy change on existing disparities in transplant rates among blood group B ethnic minorities. Herein, we present the first national study to examine the likelihood of A2i DDKT, overall and by ethnicity, in the post-KAS era. have performed one or more A2i DDKT for blood group B recipients increased from 6.9% of transplant centers in the pre-KAS period to 25.4% of transplant centers during the post-KAS period ( Figure 1 ). by recipient race (P = .75) and ethnicity (P = .08). However, recipients of A2/A2B kidneys were significantly more likely to be male (P = .003), and older than 55 years (P = .04). Recipient dialysis duration was significantly shorter among A2i recipients (P < .0001).
| MATERIAL AND ME THODS

| Statistical analysis
Recipient diabetes was borderline significant (P = .053), with greater numbers of recipients of A2i DDKT recipients having any type of diabetes. Delayed graft function was less common among recipients of A2i DDKT (P = .03). cPRA was more likely to be elevated 1.47, 95% CI 1.16-1.86, P = .005) ( Table 2) .
However, as shown in Table 2 , compared to white blood group When evaluating centers' implementation of A2i DDKT based on their proportion of AA minority patients, we found that during the pre-KAS period, blood group B DDKT recipients in centers with a low proportion of AAs among their waitlist candidates (ie, <21%), were 3.5 times as likely to receive an A2/A2B kidney compared to recipients in centers with a high proportion of AAs among blood group B waitlist candidates (i.e., > 58%) (Table 3) 
| D ISCUSS I ON
In our national case-control study of 6494 blood group B DDKT recipients from 2013 through 2017, we found an increase in the uti- TA B L E 1 (Continued) transplantation in the post-KAS era. 11 In their analysis, they also found that minority disparities in access to transplantation had shifted slightly following KAS, with AA recipients accounting for 37.8% of all recipients post-KAS, compared with 31.1% prior to the new allocation system. 11 Other studies, when analyzing general transplantation trends following KAS implementation, have also found a rise in the rate of kidney transplantation for AAs and
Hispanics following KAS, 12,13 but a lower rate for DDKT among blood group B candidates compared to other ABO groups has also been appreciated. 13 This may explain some of the differences in our findings when looking specifically at A2i transplantation rates among blood group B recipients.
Moreover, as we found in our study, the increase in minority representation in the A2i DDKT population has not been as great as expected following the implementation of KAS, and likewise the increase in minority access to transplantation does not appear great enough to counteract the disparities that still exist. Minority disparities in kidney transplantations have been found to occur on many levels, with ethnic minorities receiving fewer kidney transplants, partly due to racial differences in clinical characteristics such as blood group status, but even after accounting for clinical differences, an underutilization of kidney transplantation among minorities has been found. 14, 15 Compared to their white counterparts, end-stage renal disease disproportionately affects AAs and Asians, while both of these minority groups are less likely to undergo kidney transplantation, demonstrating the importance of continued efforts to address and reduce disparities in access to transplantation for ethnic minorities.
3,15
This study is not without limitations. This was a retrospective analysis from a large database, and as such we were restricted by the available information and may not have accounted for all potential confounding. Moreover, given the limited granularity of the data TA B L E 2 Crude and adjusted ORs and 95% CIs for the association between A2/ A2B transplantation and demographic characteristics stratified by KAS era, January 2013-February 2017
utilized, we could not account for other factors that may contribute to disparities in access to DDKT among minorities (eg, socioeconomic status). Similarly, we were unable to determine from the data why minorities did not receive a greater proportion of A2 kidneys under the new allocation system, as information such as willingness to accept A2 organs is not available from SRTR. In addition, isoagglutinin titer levels are not available from the data, and centers' reliable assessment of isoagglutinin titers may affect their ability to perform A2 incompatible transplantation. Likewise, because KAS was implemented only in December 2014, our post-KAS era was restricted to only 27 months. However, the study represents the first and largest national study to assess the impact of KAS A2/A2B → B policy on access to DDKT among minorities, and as such, provides new and important insights.
In conclusion, although we observed an increase in utilization of 
D I SCLOS U R E
The authors of this manuscript have no conflicts of interest to disclose as described by the American Journal of Transplantation. TA B L E 3 Likelihood of A2/A2B to blood group B transplantation by center proportion of AA among blood group B wait list candidates, stratified by KAS era, January 2013-February 2017
